Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

NCT04706286 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: CKD-501, D759, D150
DRUG: CKD-393 0.5/100/1000 mg

Sponsor

Chong Kun Dang Pharmaceutical